De-Escalation of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndromes

Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Dialysis

(2020) Toshiki Kuno et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52,816 Patients from 12 Randomized Trials

(2020) Eliano P. Navarese et al.   CIRCULATION

Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial

(2020) Marieke Gimbel et al.   LANCET

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

(2020) Jean-Philippe Collet et al.   EUROPEAN HEART JOURNAL

Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial

(2020) Hyo-Soo Kim et al.   LANCET

Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial

(2019) Duk-Woo Park et al.   CIRCULATION

Ticagrelor with or without Aspirin in High-Risk Patients after PCI

(2019) Roxana Mehran et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI

(2019) Daniel M.F. Claassens et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes

(2019) Stefanie Schüpke et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of Reduced-Dose Prasugrel and Standard-Dose Clopidogrel in Elderly Patients With Acute Coronary Syndromes Undergoing Early Percutaneous Revascularization

(2018) Stefano Savonitto et al.   CIRCULATION

Pharmacogenomic Approach to Selecting Antiplatelet Therapy in Patients With Acute Coronary Syndromes

(2018) Francesca Maria Notarangelo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

1-Year Outcomes of Patients Undergoing Primary Angioplasty for Myocardial Infarction Treated With Prasugrel Versus Ticagrelor

(2018) Zuzana Motovska et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

2018 ESC/EACTS Guidelines on myocardial revascularization

(2018) Franz-Josef Neumann et al.   EUROPEAN HEART JOURNAL

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

(2018) Pascal Vranckx et al.   LANCET

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

(2017) Borja Ibanez et al.   EUROPEAN HEART JOURNAL

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

(2017) Marco Valgimigli et al.   EUROPEAN HEART JOURNAL

Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study

(2017) Thomas Cuisset et al.   EUROPEAN HEART JOURNAL

Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial

(2017) Dirk Sibbing et al.   LANCET

Assessment of Ticagrelor Versus Clopidogrel Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

(2016) Xiuying Tang et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Efficacy and safety outcomes of ticagrelor compared with clopidogrel in Chinese elderly patients with acute coronary syndrome

(2016) Huidong Wang et al.   Therapeutics and Clinical Risk Management

The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations

(2015) Brian Hutton et al.   ANNALS OF INTERNAL MEDICINE

Ranking treatments in frequentist network meta-analysis works without resampling methods

(2015) Gerta Rücker et al.   BMC Medical Research Methodology

Ticagrelor vs. Clopidogrel in Japanese, Korean and Taiwanese Patients With Acute Coronary Syndrome　– Randomized, Double-Blind, Phase III PHILO Study –

(2015) Shinya Goto et al.   CIRCULATION JOURNAL

Efficacy and Safety of Adjusted-Dose Prasugrel Compared With Clopidogrel in Japanese Patients With Acute Coronary Syndrome

(2014) Shigeru Saito et al.   CIRCULATION JOURNAL

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

(2014) Ezra A. Amsterdam et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Network Meta-Analysis Using R: A Review of Currently Available Automated Packages

(2014) Binod Neupane et al.   PLoS One

Elderly Patients With Acute Coronary Syndromes Managed Without Revascularization

(2013) Matthew T. Roe et al.   CIRCULATION

Validation of the Bleeding Academic Research Consortium Definition of Bleeding in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

(2012) Gjin Ndrepepa et al.   CIRCULATION

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary

(2012) Patrick T. O'Gara et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization

(2012) Matthew T. Roe et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial

(2011) R. C. Becker et al.   EUROPEAN HEART JOURNAL

Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial

(2009) R. Mehran et al.   EUROPEAN HEART JOURNAL

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

(2009) Lars Wallentin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early and Late Benefits of Prasugrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

(2008) Elliott M. Antman et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY